Xiang Liu

Xiang Liu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2022 in Science of The Total Environment
Verified
Journal Article
Closed access
XWXiaoling Wu
Xiaoling Wu
DZDuo Zhang
Duo Zhang
YCYining Chen
Yining Chen
JSJunchun Shen
Junchun Shen
XLXiangyu Li
Xiangyu Li
SLShaoyou Lu
Shaoyou Lu

20 May 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
YSYujie Sha
Yujie Sha
DZDuo Zhang
Duo Zhang
JTJiazichao Tu
Jiazichao Tu
RZRuyue Zhang
Ruyue Zhang
YSYijia Shao
Yijia Shao
XLXiang Liu
Xiang Liu
Tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) is a widely used organophosphate ester that can adversely affect animal or human health. The intestinal microbiota is critical to human health. High-dose exposure to TDCIPP can markedly affect the intestinal ecosystem of mice, but the effects of long-term exposure to lower concentrations of TDCIPP on the intestinal flora and body metabolism remain unclear. In this study, TDCIPP was administered to Sprague-Dawley rats by gavage at a dose of 13.3 mg/kg bw/day for 90 days. TDCIPP increased the relative weight of the kidneys (P = 0.017), but had no effect on the relative weight of the heart, liver, spleen, lungs, testes, and ovaries (P > 0.05). 16 S rRNA gene sequencing revealed that long-term TDCIPP exposure affected the diversity, relative abundance, and functions of rat gut microbes. The serum metabolomics of the rats showed that TDCIPP can disrupt the serum metabolic profiles, result in the up-regulation of 26 metabolites and down-regulation of 3 metabolites, and affect multiple metabolic pathways in rat sera. In addition, the disturbed genera and metabolites were correlated. The functions of some disturbed gut microbes were consistent with the affected metabolic pathways in the sera, and these metabolic pathways were all associated with kidney disease, suggesting that TDCIPP may cause kidney injury in rats by affecting the intestinal flora and serum metabolism.

14 February 2022 in Cardiology Research and Practice
Verified
Journal Article
Open access
PDF file
XLXiang Liu
Xiang Liu
JTJiazichao Tu
Jiazichao Tu
ZZZiqin Zhou
Ziqin Zhou
BHBingxin Huang
Bingxin Huang
JZJianrong Zhou
Jianrong Zhou
JCJimei Chen
Jimei Chen
Background. Trimethylamine-N-oxide (TMAO) has been shown to be an important player in cardiovascular disease (CVD) by promoting vascular inflammation and endothelial dysfunction. We recently found that exosomes (Exos) released from TMAO-activated hepatocytes (TMAO-Exos) could significantly induce inflammation and endothelial dysfunction. However, understandings of how are the Exos secreted by hepatocytes, where are they distributed in vivo, and what effects will they have on vascular inflammation remain limited. The present study aimed to explore the hub genes involved in the production of TMAO-Exos and their distributions in vivo and effects on inflammation. Methods. The transcriptome profiles of primary rat hepatocytes stimulated with TMAO were obtained from the GSE135856 dataset in the Gene Expression Omnibus repository, and the hub genes associated with Exos were screened and verified by qPCR. Next, Exos derived from TMAO-treated hepatocytes were isolated using differential centrifugation and given intravenously to mice. After 24h, the distributions of DiI-labelled Exos were visualized with a fluorescence microscope, and the levels of proinflammatory genes in the aorta were detected by qPCR. Results. Phgdh, Mdh2, Echs1, Rap2a, Gpd1l, and Slc3a2 were identified as hub genes that may be involved in the production of TMAO-Exos. And TMAO-Exos were found to be efficiently taken up by cardiomyocytes, hepatocytes, and endothelial cells in the aorta and gastrocnemius muscle. Furthermore, TMAO-Exos, but not control-Exos, could significantly promote the mRNA expressions of Tnf, Icam1, Sele, and Cox-2 in the aorta. Conclusions. We provided clues about how TMAO may stimulate hepatocytes to produce Exos and further offered evidence that Exos secreted by TMAO-treated hepatocytes could be widely distributed in vivo and promote vascular inflammation.

1 January 2025 in Cardiovascular Therapeutics
Verified
Journal Article
Open access
YSYijia Shao
Yijia Shao
JSJiapan Sun
Jiapan Sun
XLXiang Liu
Xiang Liu
FWFang Wu
Fang Wu
ZWZhichao Wang
Zhichao Wang
LCLong Chen
Long Chen
Background and Aims: Trimethylamine‐N‐oxide (TMAO) is recognized as a novel marker and mediator of atherosclerotic cardiovascular disease (ASCVD). Endothelial progenitor cells (EPCs) are crucial for maintaining vascular homeostasis. Impaired EPC numbers and function correlate with increased adverse cardiovascular events. The aim of this study was to decipher the effect of TMAO on late EPCs (LEPCs) and its underlying molecular mechanism. Methods and Results: In vitro migration and tubulogenic capacities of LEPCs were attenuated by TMAO in a dose‐dependent manner, accompanied by inhibition of manganese superoxide dismutase (MnSOD) and mitochondrial damage. TMAO‐induced mitochondrial damage provoked proinflammatory responses (increased levels of IL‐6, IL‐1b, ICAM‐1, E‐sel, and TNF‐ α ) and autophagic cell death (confirmed by western blot immunofluorescent staining and transmission electron microscopy) in LEPCs. Overexpression of MnSOD through adenovirus transfection reversed TMAO‐related LEPCs dysfunction. To study the effect of TMAO on LEPC‐mediated vascular repair in vivo, a hind limb ischemia model was established in nude mice, and LEPCs were injected in the ischemic hind limb. Laser Doppler imaging of mouse ischemic hindlimbs at 21 days indicated that TMAO treatment inhibited LEPCs‐mediated blood flow recovery, which was restored by MnSOD overexpression. Immunohistology analyses further revealed consistent alterations in capillary density determined by CD31 staining. Conclusions: TMAO induces mitochondrial damage in LEPCs via MnSOD suppression, which leads to cell dysfunction, proinflammatory activation, and autophagic cell death in vitro and impaired LEPCs‐mediated revascularization in vivo. Overexpression of MnSOD restores TMAO‐induced LEPCs dysfunction and further enhances LEPC‐mediated revascularization in the ischemic hind limbs in nude mice.

10 December 2025 in Environmental Science: Processes & Impacts
Verified
Journal Article
Closed access
PDF file
JHJiayin Huang
Jiayin Huang
YGYiming Ge
Yiming Ge
JBJunye Bian
Junye Bian
ZGZhihui Guo
Zhihui Guo
RZRuyue Zhang
Ruyue Zhang
SLShaoyou Lu
Shaoyou Lu
Valvular heart disease (VHD) is a common cardiovascular disease, particularly among the elderly, and its social burden is increasing with the aging population in China.

18 June 2025
Verified
Journal Article
Open access
YSYijia Shao
Yijia Shao
JSJiapan Sun
Jiapan Sun
XLXiang Liu
Xiang Liu
兴刘兴 刘
兴 刘
FWFang Wu
Fang Wu
LCLong Chen
Long Chen
Background and Aims: Trimethylamine-N-oxide (TMAO) is recognized as a novel marker and mediator of atherosclerotic cardiovascular disease (ASCVD). Endothelial progenitor cells (EPCs) are crucial for maintaining vascular homeostasis. Impaired EPC numbers and function correlate with increased adverse cardiovascular events. The aim of this study was to decipher the effect of TMAO on late EPCs (LEPCs) and its underlying molecular mechanism. Methods and Results: In vitro migration and tubulogenic capacities of LEPCs were attenuated by TMAO in a dose-dependent manner, accompanied by inhibition of manganese superoxide dismutase (MnSOD) and mitochondrial damage. TMAO-induced mitochondrial damage provoked proinflammatory responses (increased levels of IL-6, IL-1b, ICAM-1, E-sel, and TNF-α) and autophagic cell death (confirmed by western blot immunofluorescent staining and transmission electron microscopy) in LEPCs. Overexpression of MnSOD through adenovirus transfection reversed TMAO-related LEPCs dysfunction. To study the effect of TMAO on LEPC-mediated vascular repair in vivo, a hind limb ischemia model was established in nude mice, and LEPCs were injected in the ischemic hind limb. Laser Doppler imaging of mouse ischemic hindlimbs at 21 days indicated that TMAO treatment inhibited LEPCs-mediated blood flow recovery, which was restored by MnSOD overexpression. Immunohistology analyses further revealed consistent alterations in capillary density determined by CD31 staining. Conclusions: TMAO induces mitochondrial damage in LEPCs via MnSOD suppression, which leads to cell dysfunction, proinflammatory activation, and autophagic cell death in vitro and impaired LEPCs-mediated revascularization in vivo. Overexpression of MnSOD restores TMAO-induced LEPCs dysfunction and further enhances LEPC-mediated revascularization in the ischemic hind limbs in nude mice.